Ikeda H, Takahashi I, Yonome I, Mitsuhashi N, Niibe H
Department of Radiology and Radiation Oncology, Gunma University School of Medicine, Japan.
Anticancer Res. 1998 Jan-Feb;18(1A):241-5.
To evaluate potential of misonidazole (MISO) as a probe for hypoxia, the biodistribution of 14C-MISO was investigated in a murine tumor model.
Following intraperitoneal injection of 14C-MISO in C57BL/6 mice with implanted meningial sarcoma tumors in the thighs, the animals were sacrificed at various times (0.5-120 hours), and 14C labeling was measured by a liquid-scintillation counter. The necrotic zone of tumor was identified by its appearance and separated from the non-necrotic tissue.
Concentration-time curves revealed a higher 14C label in the hypoxic areas, and the difference in 14C label between hypoxic and oxic areas widened as time elapsed.
These results suggest that MISO bound the hypoxic cells more firmly, and the difference in 14C label reflects differences in the bioreductive ability of MISO in these cells. These promising results indicate the feasibility of MISO analogues as a non-invasive probe for hypoxic cell identification.
为评估米索硝唑(MISO)作为缺氧探针的潜力,在小鼠肿瘤模型中研究了14C-MISO的生物分布。
给大腿植入脑膜肉瘤肿瘤的C57BL/6小鼠腹腔注射14C-MISO后,在不同时间点(0.5 - 120小时)处死动物,用液体闪烁计数器测量14C标记。通过外观识别肿瘤坏死区,并将其与非坏死组织分离。
浓度-时间曲线显示缺氧区域的14C标记较高,且随着时间推移,缺氧和有氧区域之间的14C标记差异增大。
这些结果表明MISO与缺氧细胞结合更紧密,14C标记的差异反映了MISO在这些细胞中的生物还原能力差异。这些有前景的结果表明MISO类似物作为缺氧细胞识别的非侵入性探针具有可行性。